Literature DB >> 33633370

Trends in COVID-19 therapeutic clinical trials.

Kevin Bugin, Janet Woodcock.   

Abstract

Entities:  

Year:  2021        PMID： 33633370     DOI： 10.1038/d41573-021-00037-3

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  15 in total

1.  Saving millions of lives but some resources squandered: emerging lessons from health research system pandemic achievements and challenges.

Authors:  Stephen R Hanney; Sharon E Straus; Bev J Holmes
Journal:  Health Res Policy Syst       Date:  2022-09-10

2.  Translating inspiration from COVID-19 vaccine trials to innovations in clinical cancer research.

Authors:  Noura J Choudhury; Gregory J Riely; Paul J Sabbatini; Matthew D Hellmann
Journal:  Cancer Cell       Date:  2021-05-07       Impact factor: 31.743

3.  Identification and Development of Therapeutics for COVID-19.

Authors:  Halie M Rando; Nils Wellhausen; Soumita Ghosh; Alexandra J Lee; Anna Ada Dattoli; Fengling Hu; James Brian Byrd; Diane N Rafizadeh; Ronan Lordan; Yanjun Qi; Yuchen Sun; Christian Brueffer; Jeffrey M Field; Marouen Ben Guebila; Nafisa M Jadavji; Ashwin N Skelly; Bharath Ramsundar; Jinhui Wang; Rishi Raj Goel; YoSon Park; Simina M Boca; Anthony Gitter; Casey S Greene
Journal:  mSystems       Date:  2021-11-02       Impact factor: 6.496

4.  Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic intervention.

Authors:  Yan-Ruide Li; Zachary Spencer Dunn; Gustavo Garcia; Camille Carmona; Yang Zhou; Derek Lee; Jiaji Yu; Jie Huang; Jocelyn T Kim; Vaithilingaraja Arumugaswami; Pin Wang; Lili Yang
Journal:  Stem Cell Res Ther       Date:  2022-03-21       Impact factor: 6.832

5.  Novel Strategies for the Treatment of COVID-19.

Authors:  Matthew W McCarthy
Journal:  Drugs R D       Date:  2022-08-24

6.  Development of targeted nanoparticles loaded with antiviral drugs for SARS-CoV-2 inhibition.

Authors:  Vanna Sanna; Sandro Satta; Tzung Hsiai; Mario Sechi
Journal:  Eur J Med Chem       Date:  2022-01-13       Impact factor: 6.514

Review 7.  The European clinical research response to optimise treatment of patients with COVID-19: lessons learned, future perspective, and recommendations.

Authors:  Herman Goossens; Lennie Derde; Peter Horby; Marc Bonten
Journal:  Lancet Infect Dis       Date:  2021-12-21       Impact factor: 71.421

Review 8.  Renewed rationale for sex- and gender-disaggregated research: A COVID-19 commentary review.

Authors:  Kelly Thompson; Amy Vassallo; Simon Finfer; Mark Woodward
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec

9.  Uptake of the multi-arm multi-stage (MAMS) adaptive platform approach: a trial-registry review of late-phase randomised clinical trials.

Authors:  Nurulamin M Noor; Sharon B Love; Talia Isaacs; Richard Kaplan; Mahesh K B Parmar; Matthew R Sydes
Journal:  BMJ Open       Date:  2022-03-10       Impact factor: 2.692

Review 10.  Clinical Evidence Generation During a Pandemic: Lessons Learned for Sustaining Progress.

Authors:  Donna R Rivera; Paul G Kluetz; Kald Abdallah; Sundeep Agrawal; Derek C Angus; Robert M Califf; Elizabeth Garrett-Mayer; Randall Hyer; Douglas R Lowy; Samir N Khleif
Journal:  Cancer J       Date:  2022 Mar-Apr 01       Impact factor: 2.074
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.